Abnormal uterine bleeding and prognosis of endometrial cancer

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 2, 2004, Pages 145-150

  Kimura, T ^a,c   Kamiura, S ^a   Yamamoto, T ^a   Seino Noda, H ^a   Ohira, H ^a   Saji, F ^a,b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b National Hospital Organization   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Abnormal uterine bleeding; Endometrial cancer; Prognosis

Indexed keywords

ADULT; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; DISEASE DURATION; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; UTERUS BLEEDING;

EID: 1942520308     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2003.12.001     Document Type: Article

References (12)

1. Liu J.R., Conaway M., Rodriguez G.C., Soper J.T., Clarke-Pearson D.L., Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 86:1995;486-490.
2. Nakagawa-Okamura C., Sato S., Tsuji I., Kuramoto H., Tsubono Y., Aoki D., et al. Effectiveness of mass screening for endometrial cancer. Acta Cytol. 46:2002;7-283.
3. Piver M.S., Rutledge F.N., Smith P.J. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 44:1974;265.
4. Obermair A., Hanzal E., Schreiner-Frech I., Buxbaum P., Bancher-Todesca D., Thoma M., et al. Influence of delayed on established prognostic factors in endometrial cancer. Anticancer Res. 16:1996;947-950.
5. Crawford S.C., Davis J.A., Siddiqui N.A., de Caestecker L., Gillis C.R., Hole D. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. Br Med J. 325:2002;196.
6. Granberg S., Wikland M., Karlsson B., Norstrom A., Friberg L.G. Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol. 164:1991;47-52.
7. Varner R.E., Sparks J.M., Cameron C.D., Roberts L.L., Soong S.J. Transvaginal sonography of the endometrium in postmenopausal women. Obstset Gynecol. 78:1991;195-199.
8. Osmers R.G., Osmers M., Kuhn W. Prognostic value of transvaginal sonography in asymptomatic endometrial cancers. Ultrasound Obstet Gynecol. 6:1995;103-107.
9. Gerber B., Krause A., Muller H., Reimer T., Kulz T., Kundt G., et al. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Eur J Cancer. 37:2001;64-71.
10. Koss L.G. Detection of occult endometrial carcinoma. J Cell Biochem. 23:(Suppl):1995;165-173.
11. Paley P.J. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol. 184:2001;1021-1030.
12. Dove-Edwin I., Boks D., Goff S., Kenter G.G., Carpenter R., Vasen H.F.A., et al. The outcome of endometrial carcinoma sueveillance by ultrasound scan in women at risk of hereditary non-polyposis colorectal carcinoma and familial colorectal carcinoma. Cancer. 94:2002;1708-1712.